Sponsor or institution
Clinical trials and research at Hunan Province Tumor Hospital
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Hunan Province Tumor Hospital that are recruiting, in China. By phase: Phase 2 (9), Phase 1/2 (2), Phase 3 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 1Country
Newest trials
All recruiting trials (17)
-
Infusion timing and pathologic response to neoadjuvant immunotherapy in resectable NSCLC
This trial will test whether getting immunotherapy infusions in the morning versus the afternoon changes tumor response in people with resectable stage II–III non-small cell lung cancer.
-
Investigating intrathecal pemetrexed for advanced lung cancer with brain metastases
This study is testing whether a special treatment called intrathecal pemetrexed can help people with advanced lung cancer that has spread to the brain and who haven't responded to other therapies.
-
Combination treatment for advanced lung cancer with specific mutations
This study is testing a new combination of two drugs to see if it can help people with advanced lung cancer who have certain genetic mutations live longer without their cancer getting worse.
-
Combination treatment for advanced lung cancer with specific mutations
This study is testing a new combination of two drugs for people with advanced lung cancer who have specific genetic mutations to see if it helps them live longer without their cancer getting worse.
-
Combining LMV-12 with Osimertinib for advanced lung cancer
This study is testing a new treatment combining LMV-12 with osimertinib to see if it can help people with advanced lung cancer who haven't responded to other treatments.
-
Evaluating IBI363 for treating advanced solid tumors
This study is testing a new treatment called IBI363 to see if it can help people with advanced solid tumors, like lung cancer and melanoma, feel better and improve their condition.
-
Combining immune treatment and precision radiotherapy for lung cancer brain metastasis
This study is testing a new way to treat lung cancer that has spread to the brain by combining immune therapy with targeted radiation to see if it helps patients feel better.
-
Combining chemotherapy with immune therapy for specific lung cancer mutations
This study is testing if combining chemotherapy with immune therapy can help people with specific types of lung cancer who haven't responded to other treatments.
-
Combining Pembrolizumab, Bevacizumab, and Chemotherapy for Advanced Lung Cancer with ALK Mutation
This study is testing a new combination of two drugs and chemotherapy to see if it helps people with advanced lung cancer that has an ALK mutation and hasn't improved with another treatment.
-
Evaluating chemotherapy with or without immune checkpoint inhibitors for lung cancer
This study is testing whether adding immune checkpoint inhibitors to chemotherapy can help people with non-small cell lung cancer feel better and have fewer side effects.
-
Finding biomarkers for lung cancer treatment with immune checkpoint inhibitors
This study is testing if certain biological markers can help predict side effects in lung cancer patients receiving immune checkpoint inhibitors, with or without chemotherapy.
-
Using ALK inhibitors for advanced squamous cell lung cancer
This study is testing if a medication called Crizotinib can help people with advanced squamous cell lung cancer that has a specific genetic change to live longer and feel better.
-
Combining IBI318 and Lenvatinib for advanced lung cancer treatment
This study is testing a new combination of two drugs, IBI318 and lenvatinib, to see if it can help people with advanced lung cancer who haven't had success with other treatments.
-
Exploring survival outcomes of a targeted therapy in specific lung cancer mutations
This study is testing how well a new lung cancer treatment works for patients in China with rare EGFR mutations who haven't had other cancer treatments yet.
-
Treatment options for advanced lung cancer with specific genetic mutations
This study is testing different targeted treatments for people with advanced lung cancer that have specific genetic mutations to see which ones can help them live longer and feel better.
-
Combining Anlotinib with Immune Checkpoint Inhibitors for Lung Cancer Treatment
This study is testing whether combining a drug called Anlotinib with immune treatments can help people with advanced lung cancer who haven't responded to other therapies live longer without their cancer getting worse.
-
Analyzing survival outcomes in lung cancer patients
This study looks at how different treatment choices affect the survival of lung cancer patients to see which options work best.
Quick answers
How many clinical trials run by Hunan Province Tumor Hospital are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 9, Phase 1/2: 2, Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.